Prot# SG040-0004: A Phase II Study of SGN-40 (anti-huCD40 mAb) in Patients with Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/27/07 → 12/1/11

Funding

  • Seattle Genetics, Inc. (SG040-0004)